- Report
- April 2023
- 125 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- April 2023
- 120 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- April 2023
- 126 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- April 2023
- 117 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- April 2023
- 110 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- August 2022
- 112 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- February 2024
- 114 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- February 2024
- 115 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- February 2024
- 115 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- February 2024
- 110 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- April 2023
- 130 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- April 2023
- 120 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- April 2023
- 110 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- April 2024
- 123 Pages
Global
From €2787EUR$3,160USD£2,413GBP
€3484EUR$3,950USD£3,016GBP
- Report
- September 2023
- 141 Pages
Global
From €3140EUR$3,560USD£2,718GBP
€3925EUR$4,450USD£3,397GBP
- Report
- March 2022
- 100 Pages
Global
From €3140EUR$3,560USD£2,718GBP
€3925EUR$4,450USD£3,397GBP
- Report
- August 2024
- 130 Pages
North America
From €3528EUR$4,000USD£3,054GBP
- Report
- May 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,168GBP
- Report
- May 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,168GBP
- Report
- March 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,168GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more